CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
November 19, 2019 - 3 minutes
CRISPR: A Promising Industry With Many Questions Unanswered
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
Show More
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportLatest CRISPR Articles
Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing
The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company…
October 9, 2019 - 1 minute
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
September 27, 2019 - 3 minutes
Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once
A research group at ETH Zurich, Switzerland, has made it possible to edit hundreds of…
August 15, 2019 - 3 minutes
CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
June 7, 2019 - 2 minutes
‘CRISPR Babies’ Might Be at Risk of Dying Younger
Update (01/10/2019): The scientists behind the study have declared that the results were based on…
June 3, 2019 - 3 minutes
This Biotech Uses Gene Editing to Count Chickens Before They Hatch
In the city of Jerusalem, eggXYt is developing gene edited chickens whose male chicks fluoresce…
May 24, 2019 - 3 minutes
2019 Will Be a “Year of Realism” for Biotech Investments
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At…
May 6, 2019 - 6 minutes
Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants
Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the…
April 29, 2019 - 2 minutes
Francis Mojica, the Spanish Scientist Who Discovered CRISPR
Contrary to popular belief, Francis Mojica was the first person to discover the CRISPR mechanism…
April 8, 2019 - 11 minutes
Danish Biotech to Develop CRISPR-Based Microbiome Treatments
SNIPR Biome has raised €43M in Series A funds to develop treatments that precisely target…
March 11, 2019 - 2 minutes
Swiss Scientists Find ‘Silver Bullet’ Against Bacterial Infections
Using the gene editing tool CRISPR-Cas9, researchers in Lausanne have uncovered antimicrobial molecules in the…
February 26, 2019 - 3 minutes
